The following is an excerpt from the news section of the Leopoldina website. Please note that DFG stands for the German research funding organization.
The Leopoldina, the Union of German Academies and the DFG have drafted recommendations for ensuring science-based regulation of genome edited plants in the EU. These recommendations include the amendment of European genetic engineering legislation.
Germany stands out as the European country most interested in fostering an informed debate on CRISPR many uses. Today an interdisciplinary group of experts from the German National Academy of Sciences (Leopoldina) has published a Discussion Paper entitled “Ethical and legal assessment of genome editing in research on human cells”. Experiments involving human embryos are prohibited by law in the country but the document suggests a possible compromise. Research should be permitted on “orphaned” embryos created for reproductive purposes but no longer going to be used for reproduction. In February the German academy co-organized a meeting on edited plants, discussing what kind of regulation would be suitable. In 2005 they published a statement on “The opportunities and limits of genome editing” and another one on molecular plant breeding. According to a Leopoldina official press-release, the annual assembly “will be intensively addressing the topic of genome editing” later this year.